Ovarian cancer: Weekly or 3-weekly paclitaxel are equally effective Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, March 17, 2016

Ovarian cancer: Weekly or 3-weekly paclitaxel are equally effective



Nature Reviews Clinical Oncology (req's $$$ to access)

 Patients with ovarian cancer typically receive paclitaxel plus carboplatin, and many are also treated with bevacizumab. Now, data from a randomized phase III trial comparing 3-weekly paclitaxel with a lower, weekly dose reveal no significant differences in progression-free survival (PFS) among newly-diagnosed patients with previously untreated ovarian cancer on either…
 Read the full article

0 comments :

Post a Comment

Your comments?